| Egln1 |
cytoplasm |
GO:0005737 |
| Egln1 |
cytosol |
GO:0005829 |
| Egln1 |
glutamatergic synapse |
GO:0098978 |
| Egln1 |
nucleus |
GO:0005634 |
| Egln1 |
postsynaptic density |
GO:0014069 |
| Egln1 |
2-oxoglutarate-dependent dioxygenase activity |
GO:0016706 |
| Egln1 |
enzyme binding |
GO:0019899 |
| Egln1 |
ferrous iron binding |
GO:0008198 |
| Egln1 |
L-ascorbic acid binding |
GO:0031418 |
| Egln1 |
peptidyl-proline 4-dioxygenase activity |
GO:0031545 |
| Egln1 |
peptidyl-proline dioxygenase activity |
GO:0031543 |
| Egln1 |
cardiac muscle tissue morphogenesis |
GO:0055008 |
| Egln1 |
cellular iron ion homeostasis |
GO:0006879 |
| Egln1 |
cellular response to hypoxia |
GO:0071456 |
| Egln1 |
heart trabecula formation |
GO:0060347 |
| Egln1 |
labyrinthine layer development |
GO:0060711 |
| Egln1 |
negative regulation of CAMKK-AMPK signaling cascade |
GO:1905290 |
| Egln1 |
negative regulation of cyclic-nucleotide phosphodiesterase activity |
GO:0051344 |
| Egln1 |
negative regulation of DNA-binding transcription factor activity |
GO:0043433 |
| Egln1 |
oxygen homeostasis |
GO:0032364 |
| Egln1 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline |
GO:0018401 |
| Egln1 |
positive regulation of apoptotic process |
GO:0043065 |
| Egln1 |
positive regulation of neuron death |
GO:1901216 |
| Egln1 |
positive regulation of transcription by RNA polymerase II |
GO:0045944 |
| Egln1 |
regulation of angiogenesis |
GO:0045765 |
| Egln1 |
regulation of neuron death |
GO:1901214 |
| Egln1 |
regulation of postsynapse organization |
GO:0099175 |
| Egln1 |
regulation of protein catabolic process at postsynapse, modulating synaptic transmission |
GO:0099576 |
| Egln1 |
response to hypoxia |
GO:0001666 |
| Egln1 |
response to nitric oxide |
GO:0071731 |
| Egln1 |
ventricular septum morphogenesis |
GO:0060412 |